Mitral annular calcification in high-risk patients: to operate or not to operate Authors: Ryaan EL-Andari, Maira Machhiwala, Sabin J. Bozso Published: 2026 Mitral annular calcification (MAC) refers to calcium deposition along the fibrous support structure of the mitral valve. Although it most commonly involves the posterior annulus, calcification may extend to the anterior annulus, the commissures, and even into the adjacent ventricular myocardium (1-3). The pathophysiology of MAC is unclear but may be due to several factors, including age-related degeneration, hyperlipidemia, rheumatic disease, although this most commonly impacts the leaflets, or prior radiotherapy (4). Beyond its structural implications, MAC is associated with clinical consequences such as conduction abnormalities, increased susceptibility to infective endocarditis, left ventricular hypertrophy, calcium embolism, and the need for larger prostheses during mitral valve replacement, each of which complicates operative management during mitral valve surgery (4,5). Multiple surgical strategies have been described to address MAC during mitral valve operations. Early approaches utilized en bloc decalcification followed by annular reconstruction using a pericardial patch or a dissected atrial flap (3,6,7). Though given the technical complexity, current practice favors partial MAC resection and sparing the ventricular myocardium (3,5). Additional strategies include the placement of a valve in an atrial neo-annulus or transcatheter valve replacement to deploy a valve inside the annulus without requiring resection of MAC or suturing (1,3). Hybrid approaches involve a surgical approach and exposure of the mitral valve with open atrial deployment of a transcatheter valve within the MAC, avoiding the need for extensive resection. Currently, surgical and hybrid approaches are most commonly utilized to treat MAC (8). While several options for managing MAC are available, each is associated with considerable limitations, such as the extent of operative repair and significant risk of severe complications, including atrioventricular groove disruption, bleeding, and valve dehiscence. More recently, the advent of ultrasonic emulsification devices has allowed for calcium removal while preserving surrounding myocardial tissue by removing anhydrous calcium and preserving other tissue types. This technology allows for decalcification of the mitral annulus in a targeted manner, allowing for local remodeling of the annular calcium sufficiently to allow for suture placement, while aiming to reduce the incidence of stroke, extent of resection, atrioventricular groove disruption, and coronary injury commonly occurring with traditional radical decalcification strategies (9-11). Previous literature has even demonstrated the value of ultrasonic emulsification devices in facilitating mitral valve repair in patients with MAC (11). In the manuscript by Anzai and Geirsson (12), the authors describe the case of an 82-year-old patient presenting with severe mitral regurgitation, severe MAC, and elevated surgical risk who had undergone failed transcatheter edge-to-edge repair necessitating surgical replacement of her mitral valve. The authors utilized the Sonopet surgical ultrasonic aspirator (Stryker, Kalamazoo, MI, USA) in this case, allowing for mitral valve replacement while minimizing the extent of the procedure that would have otherwise required extensive resection and patching to repair the mitral valve annulus. While the debridement was “incomplete”, leaving behind calcium, this was sufficient for the case in which a more extensive debridement and repair could have been detrimental to the patient. Several key learning points are highlighted in this manuscript and video. First, the authors highlight the importance of balancing the extent of MAC debridement and surgical risk, with this case providing an excellent example of why this balance is imperative. While complete resection of MAC and reconstruction of the mitral annulus would provide a complete repair, this was not necessary in this case. Furthermore, the patient in this report was at high surgical risk, with a failed transcatheter repair approach, and would benefit from the minimal intervention required to treat her valve disease. The second key to the aforementioned report is the focus on the appropriate anchoring of the valve. Untreated MAC is often challenging to place sutures through and may not allow for precise suture placement, increasing the risk for valve dehiscence, perivalvular leak, and an insufficient repair. Incomplete resection of MAC leaves brittle calcium that may not hold sutures effectively. In cases where complete resection of MAC and patching of the mitral annulus is not feasible, the mechanism of calcium removal with an ultrasonic emulsification device provides adequate decalcification while leaving non-calcified tissue behind. This tissue is often still not of normal quality, requiring additional techniques to ensure seating of the valve, such as incorporation of the valve leaflets, bovine pericardium, or felt to buttress the valve sutures. It is important to note that ultrasonic emulsification takes time. Patience is key with this device, as it may take several minutes of use in heavily calcified areas to soften the calcium sufficiently to allow for suture placement. Finally, this case highlights the importance of facilitating the procedure that is required for the patient. While both surgical and transcatheter interventions are available for mitral valve disease, only surgical approaches allow for all manner of valve repair. In cases where transcatheter valve repair or replacement is not feasible, even in high-risk cases, surgery remains an option to address severe valve disease. It is imperative, as with any surgical intervention, that current techniques or technologies be utilized to facilitate the procedure required for the patient while still providing an acceptable risk. In this case, minimizing risk was a priority and so utilization of the Sonopet device helped to facilitate the procedure without increasing the risk to the patient. Ongoing aspiration of the field with the Sonopet while decalcifying the mitral annulus reduces the risk of embolic stroke, while a key consideration in any case, is especially important in cases with older or frail individuals in whom even a minor stroke may impede meaningful postoperative recovery. In younger patients with an acceptable risk profile, complete resection of MAC and reconstruction of the mitral annulus may provide a more favorable long-term outcome, at the cost of short-term risk. The report published by Anzai and Geirsson illustrates that while the fundamental challenges encountered in surgery, such as MAC, remain unchanged from those described decades ago, the surgical paradigm has shifted. With variations in described techniques and modern advancements in instrumentation, surgeons have a toolkit that allows for precise and tailored approaches to managing these conditions. While transcatheter and endovascular therapies are increasingly used, they are often constrained by anatomy, leaving the most challenging, and often high-risk, cases for surgical repair. This report highlights that, even in patients with complex disease, comorbid conditions, and high risk of surgery, surgical repair is still safe and feasible when tailored to the patient. Cases such as the one reported by Anzai and Geirsson illustrate the need for continued advances in techniques and technology in cardiac surgery to allow for the management of the most complex cases. Supplementary The article’s supplementary files as Available at https://jtd.amegroups.com/article/view/10.21037/jtd-2026-0571/prf